Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.
about
Antibiotics May Trigger Mitochondrial Dysfunction Inducing Psychiatric DisordersNeurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus MonkeysDicer expression is essential for adult midbrain dopaminergic neuron maintenance and survival.A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets.Microglial phenotypes in Parkinson's disease and animal models of the disease.Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.[11C]PBR28 PET imaging is sensitive to neuroinflammation in the aged rat.Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson's Disease Rat Model.Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease.Hyperammonemia alters membrane expression of GluA1 and GluA2 subunits of AMPA receptors in hippocampus by enhancing activation of the IL-1 receptor: underlying mechanisms.
P2860
Q28816988-B4E42D01-297C-41B9-8E31-67036AF5B88BQ37579221-10E7561D-EFC4-445B-A3D4-FB3113575AF7Q37621936-A055CA83-13B2-450B-A722-C72175521F1CQ38111109-34BEE124-5124-48E5-AB1F-D907FB778E96Q38815779-670C3A2C-FCF5-41ED-816B-675E0811C228Q38949089-B102A30B-5E08-4C25-9F6C-05B3B809ADA9Q39012371-7953A574-B172-4F41-A247-3141BE85C5F4Q40923364-FA070EE7-F4C2-4663-AFAB-73468D1F13C1Q41126139-FE56101B-6CFE-4932-B594-B7B58B4C8F24Q41778722-B9622F6E-0160-44CF-AC83-925B6471AC40Q42001519-24225962-609A-43CF-9EE8-54BF3820D201Q47881099-69BC7E18-D979-442C-8292-82F624EC738AQ47916847-88168771-DC2D-47BE-BDC5-6D436502F423Q50109255-9E93DBED-79FE-4BAE-BC2B-1F04A3927DCB
P2860
Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Longitudinal and parallel moni ...... model of Parkinson's disease.
@en
Longitudinal and parallel moni ...... model of Parkinson's disease.
@nl
type
label
Longitudinal and parallel moni ...... model of Parkinson's disease.
@en
Longitudinal and parallel moni ...... model of Parkinson's disease.
@nl
prefLabel
Longitudinal and parallel moni ...... model of Parkinson's disease.
@en
Longitudinal and parallel moni ...... model of Parkinson's disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Longitudinal and parallel moni ...... model of Parkinson's disease.
@en
P2093
Emilie Vierron
Jackie Vergote
Serge Maia
Sylvie Bodard
P2860
P304
P356
10.1002/SYN.21543
P577
2012-02-15T00:00:00Z